Company Profiles

driven by the PitchBook Platform

Verax Biomedical

Description

Developer of rapid tests for the detection of bacterial contaminants in blood cells and tissue. The company provides Platelet PGD Test, a rapid test for the detection of bacterial contamination in platelets. Its products have applications for use in blood banks as well as entities engaged in blood transfusions and transplants.

1999

Founded

PRIVATE

Status

11-50

Employees

Series AA

Latest Deal Type

$12.6M

Latest Deal Amount

$58.7M

Total Amount Raised

Description

Developer of rapid tests for the detection of bacterial contaminants in blood cells and tissue. The company provides Platelet PGD Test, a rapid test for the detection of bacterial contamination in platelets. Its products have applications for use in blood banks as well as entities engaged in blood transfusions and transplants.

Website:

www.veraxbiomedical.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Primary Office

148 Bartlett Street Marlborough, MA 01752United States +1 (508) 755-7029
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Verax Biomedical's full profile, request a free trial.

Verax Biomedical Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Verax Biomedical Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Verax Biomedical Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioVentures InvestorsVenture CapitalMinority000 0000000 0000
Clark EnterprisesReal EstateMinority000 0000000 0000
CNF InvestmentsPE/BuyoutMinority000 0000000 0000
Collaborative Seed & Growth PartnersVenture CapitalMinority000 0000000 0000
KB PartnersAngel GroupMinority000 0000000 0000
BioVentures Investors Venture Capital
Clark Enterprises Real Estate
CNF Investments PE/Buyout
Collaborative Seed & Growth Partners Venture Capital
KB Partners Angel Group

Verax Biomedical Executive Team (13)

NameTitleBoard
Seat
Contact
Info
James Lousararian JDChief Executive Officer
Lisa ShinefeldDirector, Assay Development
Herbert DeanDirector, Medical Affairs
Matt MinchDirector of Sales
Joe SandersCo-Founder, Senior Vice President of Marketing and Business Development & Board Member
James Lousararian JD Chief Executive Officer
Lisa Shinefeld Director, Assay Development
Herbert Dean Director, Medical Affairs
Matt Minch Director of Sales
Joe Sanders Co-Founder, Senior Vice President of Marketing and Business Development & Board Member

Verax Biomedical Board Members (6)

NameRepresentingRoleSinceContact
Info
Buzz BensonSightLine PartnersManaging Director000 0000
James Koziarz Ph.DSelfBoard Member000 0000
Joseph GuercioClark EnterprisesManaging Director000 0000
Marc Goldberg JDBioVentures InvestorsCo-Founder, Managing Director & General Partner000 0000
Robert ZieserlSelfAngel (individual)000 0000
Buzz Benson Managing Director SightLine Partners
James Koziarz Ph.D Board Member Self
Joseph Guercio Managing Director Clark Enterprises
Marc Goldberg JD Co-Founder, Managing Director & General Partner BioVentures Investors
Robert Zieserl Angel (individual) Self
Request full access to PitchBook